Merck paid publisher to print positive stories about Vioxx, Fosamax
A science and health publisher says years ago it published what appeared to be medical journals for a group of Australian doctors that heavily favored Merck and Co.’s drugs Fosamax and Vioxx. The journals didn’t list who paid for the publishing, when in fact the publications were sponsored by Merck.